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The TGF-–Smad pathway plays a central role 
in development, maintenance, survival, and 
function  of  T  cells  (Li  and  Flavell,  2008).   
Numerous studies have reported severe inflam-
mation and death of mice with complete or   
T cell–specific lack of individual components 
of this pathway attributable to increased T cell 
activation. Foxp3-expressing regulatory T cells 
(T reg cells) suppress uncontrolled activation 
and expansion of T cells. The role of TGF-   
in the generation of T reg cells is therefore of 
special interest. There is, however, no consen-
sus on T reg cell dysfunction in various mutant 
mice. Intrathymic T reg cell development in 
mice mutant in the TGF- pathway was de-
scribed to be reduced by some (Li et al., 2006; 
Liu et al., 2008) but not others (Marie et al., 
2005, 2006; Takimoto et al., 2010). These 
studies are problematic because it is not clear 
whether the effects of a deficiency in TGF- 
signaling were cell intrinsic or not.
Experiments addressing extrathymic T reg cell   
generation suffer from the same uncertainty, even 
though there are convincing data on the conver-
sion of naive T cells into T reg cells in the gut 
where TGF- produced by antigen-presenting 
DCs appears to enhance the conversion process 
(Annacker et al., 2005; Coombes et al., 2007; 
Sun et al., 2007). DCs in the gut also produce 
retinoic acid (RA), and RA has been implicated 
to  provide  access  for  transcription  factors  like 
Smad3 to the foxp3 locus (Xu et al., 2010b).
In vitro, TGF- helps the efficient conver-
sion of naive T cells into T reg cells but Foxp3 
expression  in  these T  reg  cells  is  unstable   
(Polansky et al., 2008). In addition, in vitro ex-
periments can be misleading and are parti-
cularly misleading in this case as binding of 
phosphorylated Smad3 to the CNS1 enhancer 
is dispensable for T reg cell development (see 
subsequent text).
CORRESPONDENCE  
Harald von Boehmer: 
harald_von_boehmer@dfci.
harvard.edu
Abbreviations used: DSS, 
dextran sulfate sodium; GALT, 
gut-associated lymphoid tissue; 
IEL, intraepithelial lymphocyte; 
LPL, lamina propria lympho-
cyte; MLN, mesenteric LN;  
PP, Peyer’s patch.
Smad3 binding to the foxp3 enhancer  
is dispensable for the development of regulatory 
T cells with the exception of the gut
Susan M. Schlenner,1,2,3 Benno Weigmann,4 Qingguo Ruan,5  
Youhai Chen,5 and Harald von Boehmer1,2,6
1Laboratory of Lymphocyte Biology, Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, MA 02115
2Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115
3Department of Microbiology and Immunology, University of Leuven/ VIB, Leuven 3000, Belgium
41st Medical Clinic, University of Erlangen, Erlangen 91052, Germany
5Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
6Harvard Faculty of Arts and Sciences, Harvard University, Cambridge, MA 02138
Regulatory T cells (T reg cells) are essential for the prevention of autoimmunity throughout 
life. T reg cell development occurs intrathymically but a subset of T reg cells can also 
differentiate from naive T cells in the periphery. In vitro, Smad signaling facilitates conver-
sion of naive T cells into T reg cells but results in unstable Foxp3 expression. The TGF-–
Smad response element in the foxp3 locus is located in the CNS1 region in close proximity 
to binding sites for transcription factors implicated in TCR and retinoic acid signaling. From 
in vitro experiments it was previously postulated that foxp3 transcription represents a 
hierarchical process of transcription factor binding in which Smad3 would play a central 
role in transcription initiation. However, in vitro conditions generate T reg cells that differ 
from T reg cells encountered in vivo. To address the relevance of Smad3 binding to the 
CNS1 enhancer in vivo, we generated mice that exclusively lack the Smad binding site 
(foxp3CNS1mut). We show that binding of Smad3 to the foxp3 enhancer is dispensable for  
T reg cell development in newborn and adult mice with the exception of the gut.
© 2012 Schlenner et al.  This article is distributed under the terms of an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   
six  months  after  the  publication  date  (see  http://www.rupress.org/terms). 
After six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1530 TGF- signaling in T reg cell subset development | Schlenner et al.
is abolished. We report here that in vitro efficient conver-
sion of naive T cells into T reg cells requires binding of 
Smad3 to the enhancer binding site. In vivo, however, TGF- 
signaling through binding of Smad3 to the CNS1 is dis-
pensable for T reg cell development with the exception of 
the gut.
RESULTS AND DISCUSSION
Generation of foxp3CNS1mut mice
To study the role of Smad3 binding to the CNS1 in vivo, we 
generated a mutant mouse that selectively lacks the inverted-
repeat  binding  site  (foxp3CNS1mut;  Fig.  1). The  binding  site 
(CAGACtGTCTG) was removed by site-directed mutagenesis 
(Fig. 1 B) and this mutation of the CNS1 has been introduced 
into the foxp3 allele by gene targeting. Correct integration of 
the deletion was verified by sequencing (Fig. 1 B). The neo-
mycin resistance gene was removed in vivo by crossing chi-
meras to Cre recombinase germ line deleter mice, leaving a 
single loxP site downstream of CNS1. Consequently, Smad3 
was no longer able to bind the CNS1 as shown by ChIP 
analysis (Fig. 1 C). foxp3CNS1mut mice did not display any ap-
parent abnormalities compared with foxp3WT mice in terms 
of fertility, growth, life span, or health.
Smad3 binding contributes to TGF-–dependent  
in vitro conversion
Initially, conversion of naive T cells into T reg cells in vitro   
in the presence of TGF- and TCR stimulation was used   
to  assess  the  requirement  of  Smad  binding  to  CNS1  in   
TGF- signaling includes the phosphorylation and subse-
quent nuclear translocalization of Smad2 and Smad3 tran-
scription factors (Moustakas et al., 2001). Curiously, although 
Smad2 lacks DNA binding activity (Shi et al., 1998), it has 
been shown that both Smad2 and Smad3 contribute to TGF-–
mediated foxp3 induction and maintenance (Nolting et al., 
2009; Takimoto et al., 2010; Xu et al., 2010b).
Initiation  of  foxp3  expression  appears  to  require  some 
delicate regulation, the mechanism of which is not fully   
understood. Foxp3 gene expression is controlled by a core 
promoter and at least three enhancers (conserved noncoding 
sequences, CNS1-3; Mantel et al., 2006; Tone et al., 2008; 
Ruan et al., 2009; Xu et al., 2010b; Zheng et al., 2010). Each 
regulatory element contains a variety of transcription factor 
binding sites. CNS1 is located between exons 2b and 1 
and regulates foxp3 promoter activity. Besides a consensus 
sequence for Smad3, CNS1 harbors transcription factor binding 
sites for Rel-NFAT, CREB, RAR/RXR, and AP-1 (Tone   
et al., 2008; Ruan et al., 2009; Xu et al., 2010b). It has been 
suggested that numerous transcription factors function in a 
chronological and functional hierarchy (Ruan et al., 2009; 
Xu et al., 2010b) but these experiments rely on in vitro   
conditions that are not met in vivo.
In  TGF-–dependent  T  reg  cell–promoting  cultures 
Smad3 binding was first observed at CNS1, whereas the pro-
moter was devoid of Smad3 (Ruan et al., 2009). Later, Smad3 
dissociated from the enhancer and temporarily emerged at 
the promoter as part of a c-Rel–dependent enhanceosome. 
A model in which all components of the enhanceosome have 
to be present to turn on foxp3 expression has been suggested; 
lack of one (e.g., Smad3) would leave the promoter dormant. 
A conserved Smad consensus sequence in the promoter has been 
found; however, its role in TGF-–mediated conversion re-
mains to be determined (Samon et al., 2008). In the CNS1, an 
inverted-repeat Smad3-binding site has been described (Fig. 1; 
Tone et al., 2008). In vitro, Tone et al. (2008) showed that mu-
tation (replacement with random sequence) of this highly con-
served Smad3-binding site results in loss of Smad3 binding and 
strong but incomplete reduction of promoter activity. Although 
these studies provide a mechanistic scenario for how TGF- 
signaling can be incorporated in signaling events under 
TGF-–dependent in vitro conditions, they may be partially 
or entirely irrelevant for the generation of T reg cells in vivo.
In vivo, deletion of the complete CNS1 region (foxp3CNS1ko) 
was only correlated with reduced T reg cell numbers in gut-
associated lymphoid tissue (GALT) in aged mice, leading to   
a late onset of inflammation in the gut, as well as a defect in 
maternal-fetal tolerance resulting in increased abortion of   
allogenic embryos (Zheng et al., 2010; Samstein et al., 2012). 
The authors suggested that lack of Smad3 signaling via the 
CNS1 could be a major cause for the reduction in T reg cell 
numbers in these experiments, and in fact animals without a 
placenta do not have the CNS1 enhancer.
We generated foxp3CNS1mut mice that dissect TGF-–Smad 
signaling from other signaling pathways that affect the CNS1 
region. In these mice, only Smad binding to the enhancer 
Figure 1.  Deletion of Smad-binding site in foxp3 enhancer/CNS1. 
(A) Schematic depiction of upstream region of wild-type foxp3 locus and 
the gene targeting vector. The CNS1 and the position of the Smad-binding 
site in the wild type or deleted binding site in the foxp3CNS1mut allele are 
indicated. (B) Alignment of the wild type and the foxp3CNS1mut allele at  
the position of the Smad-binding site, showing the deleted sequence.  
(C) ChIP analysis of Smad3 binding to the foxp3 CNS1 region. foxp3WT 
(sample 1) or foxp3CNS1mut (sample 2) CD4+CD25 splenocytes were not 
stimulated (0 h) or stimulated for 1 h with TGF-, anti-CD3, and anti-
CD28. Immunoprecipitated DNA was analyzed by PCR. Data are represen-
tative of two independent experiments.JEM Vol. 209, No. 9  1531
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that phosphorylated Smad3 in foxp3CNS1mut T cells was able to 
promote T reg cell conversion as a component of the enhance-
osome at CNS1 without binding to DNA. It is possible,   
however, that other Smad-binding sites compensate for its in-
ability to bind to CNS1 in foxp3CNS1mut mice. Besides a possi-
ble binding site in the promoter, such sites have not been 
identified to date (Samon et al., 2008). We conclude that Smad3 
binding to the foxp3 enhancer is required for efficient TGF-–
dependent T reg cell conversion in vitro at low, i.e., at physio-
logically relevant TGF- levels.
Normal thymic T reg cell development  
in foxp3CNS1mut neonates
Next, we analyzed T reg cell development in vivo at two time 
points after birth but before weaning. It has been described 
that thymic T reg cell development is diminished in mice that 
lack a signaling-competent TGF-R on thymocytes and, 
therefore, have defective TGF-–Smad signaling (Li et al., 
2006; Xu et al., 2010a). In these studies, increased prolifera-
tion appeared to compensate for the reduction of thymic   
T reg cells.
To  investigate  the  role  of TGF-  signaling  through 
Smad3 binding to the foxp3 enhancer, we analyzed frequen-
cies and proliferation status of T reg cells in foxp3CNS1mut 
males and wild-type littermates at days 4 and 10 after birth 
TGF-–dependent T reg cell development. We compared 
the ability of foxp3CNS1mut and foxp3WT naive T cells to convert 
into T reg cells at different concentrations of TGF- (0–2 ng/ml; 
Fig. 2). In the absence of TGF- only marginal spontaneous 
conversion into  T reg cells took place (foxp3WT vs. foxp3CNS1mut, 
0 ng/ml TGF-, 1 ± 0.5% vs. 0.4 ± 0.2%; ±SD). foxp3CNS1mut 
naive T cells were disadvantaged under conversion conditions 
that require TGF- signaling (Fig. 2 A). Particularly at low con-
centrations of TGF-, a strong impairment in conversion of 
foxp3CNS1mut naive T cells was observed (Fig. 2, A and B). Con-
version of foxp3CNS1mut naive T cells was reduced by 61% at 0.05 
and 0.1 ng/ml TGF-, and 27% at 0.5 ng/ml TGF-, respec-
tively (foxp3WT vs. foxp3CNS1mut, 0.05 ng/ml TGF-, 6.9 ± 2.1% 
vs. 2.5 ± 0.7%; 0.1 ng/ml TGF-, 28.6 ± 7.3% vs. 12.4 ± 4.6%; 
0.5 ng/ml TGF-, 89 ± 2.5% vs. 64.2 ± 4.5%; ±SD; Fig. 2 B). 
At a TGF- concentration of 1 ng/ml, conversion rates of 
foxp3CNS1mut as well as foxp3WT cells plateaued. High concen-
trations of TGF- compensated for some of the observed im-
pairment; however, foxp3CNS1mut naive T cells did not reach 
foxp3WT conversion rates (foxp3WT vs. foxp3CNS1mut, 1 ng/ml 
TGF-, 96.4 ± 1.4% vs. 86.3 ± 4.4%; 2 ng/ml TGF-, 97.2 ± 
0.6% vs. 88 ± 6.6%; ±SD). These data are consistent with data 
by Tone et al. (2008) showing that mutation of this Smad 
binding site does not result in complete loss of foxp3 promoter 
activity. ChIP experiments (Fig. 1 C) excluded the possibility 
Figure 2.  TGF-–dependent in vitro conversion of naive T cells 
into T reg cells. (A) Frequencies of Foxp3-expressing cells among CD4+  
T cells in 2.5-d cultures containing the indicated concentrations of TGF- 
have been measured. (B) Conversion rate of foxp3CNS1mut T cells normal-
ized on conversion rate of foxp3WT T cells at the indicated TGF- concen-
trations. Data are representative of two (0.05 and 2 ng/ml TGF-) or three 
(0, 0.1, 0.5, and 1 ng/ml TGF-) independent experiments. Error bars indi-
cate means ± SEM. ***, P < 0.001; **, P < 0.01.
Figure 3.  T reg cell development in days 4 and 10 neonates. T reg 
cell frequencies among CD4+ cells have been measured in thymi, spleens, 
and intestines of day 4 (A) and day 10 (B) foxp3CNS1mut and foxp3WT mice. 
Data on day 4 T reg cell frequencies are representative of 6 foxp3CNS1mut 
and 10 foxp3WT mice and two independent experiments. Data on day 10  
T reg cell frequencies in thymus and spleen are representative of 10  
foxp3CNS1mut and 13 foxp3WT males and four independent experiments. 
Data for day 10 T reg cell frequencies in intestine are representative of six 
foxp3CNS1mut and eight foxp3WT males and two independent experiments. 
Error bars indicate means ± SEM.1532 TGF- signaling in T reg cell subset development | Schlenner et al.
These data show that the develop-
ment of the first wave of thymic   
T reg cells does not require Smad3 
binding to the CNS1 and refute im-
plications of the mentioned studies 
on a role of TGF-–Smad signaling 
in early intrathymic T reg cell devel-
opment. It appears that T reg cells 
with  an  intrinsic TGF-  signaling 
defect develop normally in newborns.
Normal T reg cell frequencies in young  
adult foxp3CNS1mut mice
We then investigated mice at 4 (Fig. 4 A) and 8 (Fig. 4 B) wk 
of age. Thymus, spleen, axial/inguinal LN, mesenteric LN 
(MLN), Peyer’s patches (PPs), lamina propria lymphocytes 
(LPLs), and intraepithelial lymphocytes (IELs) were analyzed 
with regard to their frequency of T reg cells among CD4+  
T cells (Fig. 4, A and B, top) as well as Helios expression 
among T reg cells isolated from these sites (Fig. 4, A and B, 
bottom). Foxp3CNS1mut and foxp3WT mice were furthermore 
injected with EdU 16 h before analysis, and the proliferation 
status of T reg cells was assessed (Fig. 4, A and B, middle).
foxp3CNS1mut T reg cells appeared at normal frequencies 
and the proportion of Helios-expressing T reg cells among 
foxp3CNS1mut T reg cells appeared comparable to foxp3WT litter-
mates at both time points. From 4 to 8 wk there is a mild in-
crease in the Helios/Helios+ ratio in several organs (thymus, 
spleen, LN, and MLN), whereas others remain unchanged (PP, 
LPL, and IEL). Helios expression has been suggested to distin-
guish peripherally converted from intrathymically generated   
T reg cells (Thornton et al., 2010). However, the mechanisms of 
Helios activation and regulation of expression are unclear, and 
Helios has also been associated with T cell activation and T helper 
cell differentiation (Akimova et al., 2011; Serre et al., 2011). 
(Fig. 3). Around day 3 of age, T reg cells first appear in the 
thymus (Kim and Rudensky, 2006). We analyzed the appear-
ance of thymic as well as splenic and intestinal T reg cells at 
day 4. Comparable frequencies of T reg cells were found in 
foxp3WT versus foxp3CNS1mut mice in all three organs (foxp3WT 
vs. foxp3CNS1mut thymi, 3.6 ± 0.8% vs. 3.5 ± 0.4%; spleens, 
6.8 ± 1.4% vs. 7.3 ± 1.1%; intestines, 5.2 ± 1.6% vs. 6.5 ± 
4.2%; ±SD; Fig. 3 A).
As shown in Fig. 3 B, T reg cell frequencies increased   
in all three organs between 4- and 10-d-old mice with no 
apparent difference between foxp3CNS1mut mice and foxp3WT 
mice at day 10 (foxp3WT vs. foxp3CNS1mut thymi, 4.5 ± 0.7% vs.   
4.0 ± 0.7%; spleens, 10.7 ± 2.2% vs. 10.8 ± 1.4%; intestines,   
7 ± 0.9% vs. 7.9 ± 0.8%; ±SD). To analyze the proliferation 
of T reg cells, day 10 newborns were injected i.p. with EdU 
16 h before analysis. There was no evidence that elevated 
proliferation contributed to similar T reg cell levels in differ-
ent mice (foxp3WT vs. foxp3CNS1mut thymi, 23.3 ± 1.8% vs.   
24 ± 3%; spleens, 21.4 ± 2.4% vs. 21.8 ± 1.6%; ±SD; unpub-
lished data).
In agreement with previous studies by Thornton et al. 
(2010), virtually all T reg cells in newborn mice expressed the 
transcription factor Helios as assessed by intracellular staining 
in spleen and intestine of day 10 mice (unpublished data). 
Figure 4.  Analysis of T reg cell fre-
quencies, proliferation rate, and propor-
tion of Helios-expressing T reg cells  
in adult males. 4-wk-old (A), 8-wk-old  
(B), and 6-mo-old (C) males have been 
injected with 1 mg EdU i.p. 16 h before 
analysis. (A and B) Thymi (thy), spleen (spl), 
axial/inguinal LN, MLN, PP, LPL, and IEL  
have been analyzed for frequency of Foxp3+ 
T reg cells among CD4+ T cells (top), EdU+ 
(middle), and Helios+ (bottom) cells among  
T reg cells. Data are representative of two  
to six males and two to three independent 
experiments per group. (C) Frequencies of 
T reg cells (left) and EdU+ T reg cells (right) 
were assessed in spleen, PP, LPL, and IEL. 
Data are representative of 7–10 males and 
five independent experiments per group. 
Data for foxp3WT mice are depicted in black 
and data for foxp3CNS1mut mice are depicted 
in gray. Error bars indicate means ± SEM.  
*, P < 0.03.JEM Vol. 209, No. 9  1533
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under  pathological  conditions,  we  investigated  two  colitis 
models in age-matched foxp3CNS1mut and foxp3WT mice (Fig. 5). 
3-mo-old mice were subjected to dextran sulfate sodium (DSS) 
in drinking water. DSS-induced colitis is a common colitis 
model in which DSS induces inflammation by its toxic effects 
on colonic epithelium leading to activation of innate immune 
cells, followed by activation of the adaptive immune system.   
T reg cells residing in the gut mucosa are able to interfere with 
the inflammation. Because DSS-induced colitis appears to   
be indirectly mediated by T cells, we also investigated the   
T cell–transfer colitis model transferring foxp3CNS1mut or foxp3WT 
naive T cells, respectively, into Rag-deficient hosts (Fig. 5). 
In this model, some of the transferred naive T cells undergo 
acute conversion into T reg cells, which can interfere with the 
developing colonic inflammation.
In both conditions, similar weight losses were observed 
between both groups (Fig. 5, top left graph; and not depicted) 
and similar colitis severity scores were obtained (Fig. 5, top 
right graph). Furthermore, mini-endoscopy and HE staining 
of colon (day 7 in DSS-induced colitis, day 45 in T cell trans-
fer colitis) revealed similar signs of inflammation such as 
thickening of the wall, loss of crypt architecture, ulcers, and 
accumulation of mononuclear cells. In conclusion, although 
the gut T reg cell frequency in mice older than 2 mo is par-
tially negatively affected by mutations of the enhancer re-
gion, this defect does not increase the susceptibility of mutant 
Particularly interesting is the fact that gut-associated T reg cells 
appeared normal in terms of T reg cell numbers and T reg cells 
did not show any compensatory proliferation.
Generally, although proliferation of T reg cells strongly 
declines in all organs within 4–8 wk of age, and consider-
ing that thymic output does not further increase, it appears   
remarkable that T reg cell proportions among CD4+ T cells   
are held constant in all organs analyzed in foxp3CNS1mut and 
foxp3WT mice. Possible explanations for this observation could 
be that a plateau is reached by thymic T reg cells or the contribu-
tion of peripheral conversion increases during 4–8 wk of age.
Smad3 binding contributes to T reg cell conversion  
in GALT in older mice
We  hypothesized  that  a  possible  positive  impact  of  Smad3 
binding on foxp3 promoter activation would become apparent 
at later ages. We analyzed 6-mo-old mice in which thymic out-
put had declined. The frequency and proliferation of splenic   
T reg cells as well as T reg cells among IEL, LPL, and PP lympho-
cytes of foxp3CNS1mut mice were compared with their wild-type 
counterparts (Fig. 4 C). Although splenic T reg cell numbers 
appeared to be similar, an appreciable reduction in T reg cell 
frequency was found to be apparent in PP and LPL (foxp3WT vs. 
foxp3CNS1mut spleen, 18.2 ± 1.9% vs. 19.3 ± 2.2% [P = 0.206]; 
PP, 23.6 ± 4.7% vs. 19.3 ± 2.2% [P = 0.0157]; LPL, 20.5 ± 
7.2% vs. 13.7 ± 5.2% [P = 0.0288]; IEL, 7.6 ± 4.5% vs. 10.4 ± 
5.3% [P = 0.2654]; ±SD; Fig. 4 C, left).
A reduction of T reg cells in PP and LPL has also been   
reported in aged foxp3CNS1ko mice (Zheng et al., 2010). The   
reduction observed by Zheng et al. (2010) in foxp3CNS1ko mice 
(50%) was more profound than T reg cell reduction in   
foxp3CNS1mut mice (20% in PP and 35% in LPL), which might 
be explained by the contribution of other transcription factor 
binding sites present in the CNS1. Consistent with the possi-
bility of compensation for reduced T reg cell numbers by in-
creased proliferation we observed a tendency of T reg cells, 
particularly among LPL, for slightly elevated proliferative   
activity (foxp3WT vs. foxp3CNS1mut spleen, 2.5 ± 0.7% vs. 2.9 ± 
0.8% [P = 0.3226]; PP, 1.7 ± 0.6% vs. 2.1 ± 0.5% [P = 0.1353]; 
LPL, 1.6 ± 0.8% vs. 2.6 ± 0.8% [P = 0.0241]; IEL, 2.9 ± 1.4% vs. 
3.8 ± 1.3% [P = 0.2103]; ±SD; Fig. 4 C, right). This may mask 
a more profound defect in gut-associated T reg cell generation 
in foxp3CNS1mut mice as well as in foxp3CNS1ko mice.
We furthermore found the frequency of activated T cells 
(CD4+CD62L/loCD44hi) in axial/brachial LN to be compa-
rable in foxp3CNS1mut and foxp3WT mice. In addition, no histo-
logical evidence for increased lymphocyte migration into liver, 
lung, kidney, pancreas, stomach, or colon in foxp3CNS1mut mice 
could be found (unpublished data). In conclusion,  TGF-–Smad3 
signaling via binding of Smad3 to the foxp3 enhancer partially 
helps the conversion of CD4+ T cells into T reg cells in the gut.
Partial reduction in GALT T reg cells does not increase 
susceptibility of foxp3CNS1mut mice to colitis
To investigate whether a mild defect in the generation or main-
tenance of gut T reg cells affects regulation of T cell activation 
Figure 5.  Analysis of T cell transfer colitis. Naive T cells from foxp3WT 
mice (blue) or foxp3CNS1mut mice (red), respectively, have been transferred 
into Rag-deficient recipient mice. Body weight was measured (top left) 
and, at day 45, colitis activity was determined by mini-endoscopy and 
analyzed in colitis score (top right). Histological analysis of colons at  
day 45 after transfer showed similar signs of inflammation like in DSS-
induced colitis. Data are representative of eight mice and two indepen-
dent experiments per group. Error bars indicate means ± SEM.1534 TGF- signaling in T reg cell subset development | Schlenner et al.
FCS), and 5–9 PPs were excised from a small intestine and incubated for two 
rounds of rotation (20 min at 37°C) in freshly prepared HBSS/10 mM 
Hepes/20% FCS/0.5 mM DTT/1 mM EDTA with strong vortexing after 
each round to remove epithelial cells and IEL. Single cell suspensions were pre-
pared using frosted glass slides in FACS staining buffer (PBS/5% FCS). The in-
testines were opened longitudinally and cut into 0.5–1-cm pieces. To remove 
mucus, pieces were vortexed in large volume of RPMI 1640 for several rounds. 
IELs were recovered by incubation as described for PP, and suspension cells were 
roughly filtered through a metal filter and applied to gradient centrifugation as 
follows: cells of one intestine were resuspended in 24 ml of ice-cold 40% Percoll, 
pH 7.2, distributed over three FCS-precoated 15-ml tubes, underlaid with 5 ml 
of ice-cold 100% Percoll, pH 7.2, and centrifuged for 20 min at 600 g and 4°C 
with no brake. After centrifugation, the top layer was discarded and the inter-
phase containing IEL was recovered. Intestinal pieces after IEL/epithelial cells 
removal were digested in HBSS/10 mM Hepes/80 CDU/ml Liberase-TM 
(Roche)/25 µg/ml DNase I (Roche) in three rounds of rotation (30 min at 
37°C) with strong vortexing or pipetting after each digestion cycle. After com-
plete digestion of the tissue, suspension cells were filtered as for IEL and applied 
to gradient centrifugation as for IEL in one to two 15-ml tubes per organ.
Isolation of CD4+ T cells from intestines of newborns. The entire   
intestine of day 4 or 10 newborns was minced and digested with 100 U/ml 
Collagenase (Gibco) in three to four rounds of 30 min each at 37°C. Recovered 
suspension cells were filtered, unspecific binding sites were blocked with 
anti-CD16/32, and cells were than stained with biotinylated anti-CD4 
antibody. CD4+ cells were enriched by MACS using magnetic streptavidin 
beads (Miltenyi Biotec) and LS columns (Miltenyi Biotec).
Induction of colitis. Colitis was induced by three cycles of 2% DSS (MP 
Biomedicals) in drinking water for 1 wk and normal drinking water for   
2 wk. Transfer colitis was induced by adoptive transfer of naive CD4+CD25 
T cell in Rag/ hosts. In brief, CD4+ T cells were purified by negative   
selection from spleen mononuclear cells of foxp3CNS1mut or foxp3WT mice,   
respectively,  using  MACS  system  (Miltenyi  Biotec). The  resulting  CD4+  
T cells were further enriched for CD24+ cells by immunomagnetic beads 
into CD24+ cells and transferred into RAG-1–deficient mice. Colitis activity 
was monitored by weight curves, endoscopy, and histological analysis, as specified 
in the next sections. Mice were maintained in isolated cages under specific 
pathogen-free conditions. No evidence of graft versus host disease, such as 
skin inflammation and histopathological evidence of small bowel inflammation, 
was observed in the reconstituted animals.
Mini-endoscopic  analysis. Colitis development was monitored with a 
high-resolution video endoscopic system (Karl Storz). Scoring of DSS colitis 
severity was performed according to MEICS score with five parameters 
(translucency, granularity, vascularity, fibrin production, and stool).
Flow cytometry, antibodies, and EdU. For cell surface staining, cells 
were blocked with anti-CD16/32 (2.4G2; BD) and subsequently stained with 
antibodies in PBS/5% FCS for 45 min on ice. Cell sorting and analyses 
were  performed  on  FACSAria.  For  intracellular  staining,  cells  were  first 
stained for surface molecules, subsequently fixed and permeabilized in the 
presence of blocking antibody (eBioscience, 00–5521), and then stained for 
30 min with anti-Foxp3 (FJK-16s; eBioscience) and anti-Helios (22F6; Bio-
Legend). For analysis of EdU incorporation, the supplier’s manual was fol-
lowed (Molecular Probes). In brief, newborn mice were injected with 500 µg 
and adult mice i.p. with 1 mg EdU 16 h before analysis. Recovered cells were 
stained for surface and intracellular molecules as described in previous sec-
tions, washed twice with foxp3 staining kit permeabilization buffer and once 
with EdU staining kit permeabilization buffer, and subsequently resuspended 
in EdU reaction solution. EdU reaction was allowed to run for 35 min, and 
cells were washed three times in EdU staining kit permeabilization buffer and 
resuspended in PBS/5% FCS. Further antibodies used were CD4 (GK1.5), 
CD25 (PC61), CD44 (IM7), CD62L (MEL-14), and CD45 (30-F11; all 
from BioLegend).
mice to T cell–independent or T cell–dependent colitis. Sim-
ilar results were previously obtained in CNS1-deficient mice 
(Zheng et al., 2010).
TGF- influences all stages of a T cell’s life. Regarding the 
TGF-–Smad signaling in T reg cells, previous studies sug-
gested a dominant role of Smad3 binding to the foxp3 locus 
in T reg cell development. The Smad3 binding site in CNS1 
is considered the crucial regulatory element by which TGF- 
signals to the foxp3 locus. In vitro, CNS1-bound Smad3 con-
tributes to foxp3 initiation (Tone et al., 2008; Ruan et al., 
2009). Consistently, deletion of the entire CNS1 (removal of   
several transcription factor binding sites) resulted in decreased 
TGF-–dependent in vitro conversion of naive T cells into T reg 
cells (Zheng et al., 2010). Contrary to previous in vivo studies, 
despite abrogated TGF- signaling in T reg cells, CNS1- 
deficient  mice  were  healthy.  By  exclusively  removing  the   
Smad3-binding site from the CNS1 we were then able to nar-
row down T reg cell reduction in GALT to Smad3 signaling, dis-
secting it from roles of other transcription factors. Here, we 
provide direct evidence that binding of Smad3 to the foxp3 
CNS1 is dispensable for T reg cell development with the excep-
tion of the gut.
MATERIALS AND METHODS
Gene targeting and mice. The foxp3CNS1mut gene targeting vector con-
sisted of a 5 long homologous arm (1468 to +3289 bp), a loxP2272-
flanked neomycin resistance gene in opposite orientation to the locus, 
and a 3 short homologous arm (+3290 to +4985 bp;  and + refer to   
upstream or  downstream  of  transcriptional  start,  respectively;  Ensembl   
ENSMUST00000115740). The Smad-binding site in the enhancer was de-
leted by site-directed mutagenesis (Sawano and Miyawaki, 2000), confirmed 
by PCR and sequencing, and foxp3CNS1mut embryonic stem (ES) cells were 
generated by gene targeting in v6.5 ES cells (129/B6 F1 hybrid). Chimeric 
mice were bred to germline Cre recombinase deleter mice (B6.FVB-
Tg(EIIa-cre)C5379Lmgd/J). The mutant allele was then crossed to B6 for   
at  least  two  generations.  All  animal  care  and  procedures  were  executed   
according to National Institutes of Health guidelines and in accordance with 
the guidelines of the Animal Care and Use Committee of the Dana Farber 
Cancer Institute.
ChIP  analysis. CD4+CD25 splenocytes were enriched using the Easy-
Sep mouse CD4+ T cell enrichment kit (STEMCELL Technologies) and 
CD25 Microbead kit (Miltenyi Biotec). The cells were stimulated for 1 h 
in the presence of 5 ng/ml TGF-, 5 µg/ml anti-CD3 (precoated), and 
1 µg/ml anti-CD28. Cell lysates were immunoprecipitated with anti-Smad3   
(Abcam) or control IgG using the ChIP-IT Express kit (Active Motif).   
Immunoprecipitated DNA was analyzed by PCR (enhancer-1 forward,   
5-CCCATGTTGGCTTCCAGTCTCCTTTATGG-3; enhancer-1 reverse,   
5-AGGTACAGAGAGGTTAAGAGCCTGGGT-3, product size 156 bp).
In  vitro  conversion.  Naive  T  cells  (Sytox  blue  [Invitrogen]-negative 
CD4+CD25CD44/loCD62Lhi) were sorted from spleen and LN to >98% 
purity and an aliquot was used for intracellular staining for foxp3. 96-well cul-
ture plates were coated with 5 µg/ml anti-CD3 in PBS for 75 min at 37°C. 
50,000 naive T cells were plated per well in 200 µl medium (RMPI 1640, 10% 
FCS, penicillin/streptomycin, gentamicin, 1× GlutaMAX, 1× nonessential 
amino acids, 1× sodium pyruvate, -mercaptoethanol, 100 U/ml mIL-2, and 
0–2 ng TGF-/ml) for 2.5 d. Culture medium components were purchased 
from Gibco, rmIL-2 from PeproTech, and rhTGF1 from R&D Systems.
Isolation of PPs, IELs, and LPLs. The small intestines were cleaned from 
fat and connective tissue and flushed with CMF (HBSS/10 mM Hepes/2% JEM Vol. 209, No. 9  1535
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Histology. Whole mice were fixed in Bouin’s solution for 72 h and subse-
quently kept in 70% ethanol solution until organs were recovered. Organs 
were embedded in paraffin, and hematoxylin and eosin staining for general 
morphology was performed.
Statistics. Unpaired Student’s t test was used to determine the p-value in 
Prism (GraphPad Software).
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